New Stock News | Irish health technology company EveryBaby said it intends to IPO in Hong Kong in the future in the form of 18A.

Dabriel Choi, CEO of the Irish health technology company EveryBaby, announced at a media luncheon that they plan to raise funds later this year, intending to sell 20% of shares and introduce digital and medical-related investors from the US. They are considering listing in Hong Kong in the form of an 18A (for biotechnology companies without profits or income) IPO in the future, but currently do not have a timeline. The company specializes in analyzing cervical tissue to prevent premature births, and is fully owned by Dabriel Choi. He mentioned that he works in London personally, while the headquarters for the Asia region is located in Hong Kong, due to its strong medical infrastructure and strategic position for entering the mainland market. Additionally, EveryBaby is expanding into the Middle East market and has opened an office in the UAE. InvestHK held a Women's Health and Technology Forum for 2025 today, bringing together outstanding representatives from the government, academia, and private sector to discuss the relationship between technology and women's health. The forum and its media activities covered topics such as policy initiatives, clinical research, and ecosystem development, attracting key stakeholders interested in developing medical health in Hong Kong.